Table 1.
Parameter | Description |
---|---|
Population (P) | Adult patients (age 18+) with heart failure |
Intervention (I) | Hematopoietic stem cell therapy |
Comparison (C) | Hematopoietic stem cell therapy or placebo or pre-therapy (baseline) measures or post-therapy measures |
Outcome (O) | Peak VO2, New York Heart Association (NYHA) symptom class, major adverse cardiovascular events, ejection fraction, duration of follow-up appointments |